ECONAZOLE NITRATE (UNII: H438WYN10E) (ECONAZOLE - UNII:6Z1Y2V4A7M) - search results

United States - English - NLM (National Library of Medicine)

pm external- econazole nitrate, salicylic acid, lidocaine, l-menthol solution

oasis trading - levomenthol (unii: bz1r15mtk7) (levomenthol - unii:bz1r15mtk7), salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz), lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), econazole nitrate (unii: h438wyn10e) (econazole - unii:6z1y2v4a7m) - when left untreated, the symptoms can be painful, unsightly, and make walking difficult. here are the most common symptoms: itching or burning between your toes or on the soles of your feet white, wet-looking skin in between your toes flaky skin or small tears (fissures) on feet or in-between toes red rash between the toes blisters or ulcers on the skin on top of foot broken blisters, causing pain and swelling thick, dry, scaly skin on the bottom and sides of feet ■first wash and dry your feet thoroughly ■ adults and children 2 years of age and older: apply to the affected area no more than 3 to 4 times daily ■ children under 2 years of age: consult a doctor

United States - English - NLM (National Library of Medicine)

vivjoa- oteseconazole capsule

mycovia pharmaceuticals, inc. - oteseconazole (unii: vhh774w97n) (oteseconazole - unii:vhh774w97n) - vivjoa is indicated to reduce the incidence of recurrent vulvovaginal candidiasis (rvvc) in females with a history of rvvc who are not of reproductive potential [see warnings and precautions (5.1), use in specific populations (8.3), and clinical studies (14)] . if specimens for fungal culture are obtained prior to therapy, antifungal therapy may be instituted before the results of the cultures are known. however, once these results become available, antifungal therapy should be adjusted accordingly. vivjoa is contraindicated in: - females of reproductive potential [see warnings and precautions (5.1) and use in specific populations (8.3)] - pregnant and lactating women [see warnings and precautions (5.1), and use in specific populations (8.1, 8.2)] - patients with known hypersensitivity to oteseconazole